Page 30 - GPD-2-4
P. 30
Gene & Protein in Disease The roles and mechanisms of ETS1 in diseases
transcription factor. Gene, 711: 143952. https://doi.org/10.1016/j.bbrc.2015.04.075
https://doi.org/10.1016/j.gene.2019.143952 53. Xu C, Liu S, Fu H, et al., 2010, MicroRNA-193b regulates
proliferation, migration and invasion in human
43. Ito H, Duxbury M, Benoit E, et al., 2004, Prostaglandin E2
enhances pancreatic cancer invasiveness through an Ets-1- hepatocellular carcinoma cells. Eur J Cancer, 46(15): 2828–
dependent induction of matrix metalloproteinase-2. Cancer 2836.
Res, 64(20): 7439–7446. https://doi.org/10.1016/j.ejca.2010.06.127
https://doi.org/10.1158/0008-5472.CAN-04-1177 54. Allam MM, Diab KA, Khalil FO, et al., 2022, The association
between micro-RNA gene polymorphisms and the
44. Gao H, Peng C, Liang B, et al., 2014, beta6 integrin induces the
expression of metalloproteinase-3 and metalloproteinase-9 development of hepatocellular carcinoma in Egyptian
in colon cancer cells via ERK-ETS1 pathway. Cancer Lett, patients. Arch Med Sci, 18(1): 62–70.
354(2): 427–437. https://doi.org/10.5114/aoms/100600
https://doi.org/10.1016/j.canlet.2014.08.017 55. Zheng L, Qi T, Yang D, et al., 2013, microRNA-9 suppresses
the proliferation, invasion and metastasis of gastric cancer
45. Tsai CL, Jung SM, Chi LM, et al., 2021, Glycogen synthase
kinase-3 beta (GSK3beta)-mediated phosphorylation of cells through targeting cyclin D1 and Ets1. PLoS One, 8(1):
ETS1 promotes progression of ovarian carcinoma. Aging e55719.
(Albany NY), 13(10): 13739–13763. https://doi.org/10.1371/journal.pone.0055719
https://doi.org/10.18632/aging.202966 56. Zheng L, Pu J, Qi T, et al., 2013, miRNA-145 targets v-ets
erythroblastosis virus E26 oncogene homolog 1 to suppress
46. Phuchareon J, McCormick F, Eisele DW, et al., 2015, EGFR
inhibition evokes innate drug resistance in lung cancer the invasion, metastasis, and angiogenesis of gastric cancer
cells by preventing Akt activity and thus inactivating Ets-1 cells. Mol Cancer Res, 11(2): 182–193.
function. Proc Natl Acad Sci U S A, 112(29): E3855–E3863. https://doi.org/10.1158/1541-7786.MCR-12-0534
https://doi.org/10.1073/pnas.1510733112 57. Zhang Y, Yan LX, Wu QN, et al., 2011, miR-125b is methylated
and functions as a tumor suppressor by regulating the ETS1
47. Seidel JJ, Graves BJ, 2002, An ERK2 docking site in the
Pointed domain distinguishes a subset of ETS transcription proto-oncogene in human invasive breast cancer. Cancer
factors. Genes Dev, 16(1): 127–137. Res, 71(10): 3552–3562.
https://doi.org/10.1158/0008-5472.CAN-10-2435
https://doi.org/10.1101/gad.950902
58. Li W, Zang W, Liu P, et al., 2014, MicroRNA-124 inhibits
48. Myers E, Hill AD, Kelly G, et al., 2005, Associations and
interactions between Ets-1 and Ets-2 and coregulatory cellular proliferation and invasion by targeting Ets-1 in
proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin breast cancer. Tumour Biol, 35(11): 10897–10904.
Cancer Res, 11(6): 2111–2122. https://doi.org/10.1007/s13277-014-2402-2
https://doi.org/10.1158/1078-0432.CCR-04-1192 59. Wang R, Ma Y, Yu D, et al., 2015, miR-377 functions as a
tumor suppressor in human clear cell renal cell carcinoma
49. Tomar S, Plotnik JP, Haley J, et al., 2018, ETS1 induction by
the microenvironment promotes ovarian cancer metastasis by targeting ETS1. Biomed Pharmacother, 70: 64–71.
through focal adhesion kinase. Cancer Lett, 414: 190–204. https://doi.org/10.1016/j.biopha.2015.01.012
https://doi.org/10.1016/j.canlet.2017.11.012 60. Hua S, Lei L, Deng L, et al., 2018, miR-139-5p inhibits
aerobic glycolysis, cell proliferation, migration, and invasion
50. Ning S, Chao HJ, Li S, et al., 2022, The auto-inhibition
mechanism of transcription factor Ets-1 induced by in hepatocellular carcinoma via a reciprocal regulatory
phosphorylation on the intrinsically disordered region. interaction with ETS1. Oncogene, 37(12): 1624–1636.
Comput Struct Biotechnol J, 20: 1132–1141. https://doi.org/10.1038/s41388-017-0057-3
https://doi.org/10.1016/j.csbj.2022.02.025 61. Zhai W, Ma J, Zhu R, et al., 2018, MiR-532-5p suppresses
renal cancer cell proliferation by disrupting the ETS1-
51. Wei W, Hu Z, Fu H, et al., 2012, MicroRNA-1 and
microRNA-499 downregulate the expression of the ets1 mediated positive feedback loop with the KRAS-NAP1L1/P-
proto-oncogene in HepG2 cells. Oncol Rep, 28(2): 701–706. ERK axis. Br J Cancer, 119(5): 591–604.
https://doi.org/10.1038/s41416-018-0196-5
https://doi.org/10.3892/or.2012.1850
62. Jin L, Huang S, Guan C, et al., 2020, ETS1-activated
52. Ma N, Chen F, Shen SL, et al., 2015, MicroRNA-129-5p
inhibits hepatocellular carcinoma cell metastasis and SNHG10 exerts oncogenic functions in glioma via targeting
invasion via targeting ETS1. Biochem Biophys Res Commun, miR-532-3p/FBXL19 axis. Cancer Cell Int, 20(1): 589.
461(4): 618–623. https://doi.org/10.1186/s12935-020-01649-2
Volume 2 Issue 4 (2023) 9 https://doi.org/10.36922/gpd.2141

